Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Other Working Capital Changes (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Other Working Capital Changes data on record, last reported at $345000.0 in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 144.92% year-over-year to $345000.0; the TTM value through Dec 2025 reached $2.9 million, changed N/A, while the annual FY2025 figure was $5.1 million, 265.77% up from the prior year.
  • Other Working Capital Changes reached $345000.0 in Q4 2025 per CAI's latest filing, down from $2.5 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.5 million in Q3 2025 and bottomed at -$768000.0 in Q4 2024.